Clinical Trial Update: A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 Diabetes [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports on safety, tolerability, and effects on plasma glucose after multiple ascending oral doses of AZD1656 in individuals with Type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD1656

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED